Terry Savage - CME Independent Director

CHME34 Stock  BRL 325.51  0.00  0.00%   

Insider

Terry Savage is Independent Director of CME Group since 2003.
Age 74
Tenure 21 years
Phone312 930 1000
Webhttps://www.cmegroup.com

CME Management Efficiency

The company has return on total asset (ROA) of 0.0102 % which means that it generated a profit of $0.0102 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0992 %, meaning that it generated $0.0992 on every $100 dollars invested by stockholders. CME's management efficiency ratios could be used to measure how well CME manages its routine affairs as well as how well it operates its assets and liabilities.
CME Group has accumulated 3.42 B in total debt with debt to equity ratio (D/E) of 0.15, which may suggest the company is not taking enough advantage from borrowing. CME Group has a current ratio of 1.0, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist CME until it has trouble settling it off, either with new capital or with free cash flow. So, CME's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CME Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CME to invest in growth at high rates of return. When we think about CME's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christopher SuhElectronic Arts
53
Chris EvendenElectronic Arts
N/A
David TinsonElectronic Arts
N/A
Andrew MurchieMarfrig Global Foods
N/A
Rafael BrazMarfrig Global Foods
N/A
Roberto WaackMarfrig Global Foods
N/A
Laura MieleElectronic Arts
53
Vijayanthimala SinghElectronic Arts
52
Eric KellyElectronic Arts
51
Andrew WilsonElectronic Arts
48
Rodrigo FilhoMarfrig Global Foods
49
Jacob SchatzElectronic Arts
54
Eduardo PuzzielloMarfrig Global Foods
N/A
Frank RavndalMarfrig Global Foods
62
John ReseburgElectronic Arts
N/A
Paulo PianezMarfrig Global Foods
N/A
Marcelo AriasMarfrig Global Foods
N/A
Christopher BruzzoElectronic Arts
53
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME GROUP operates under Financial Data Stock Exchanges classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 4370 people. CME Group (CHME34) is traded on Sao Paulo Exchange in Brazil and employs 37 people.

Management Performance

CME Group Leadership Team

Elected by the shareholders, the CME's board of directors comprises two types of representatives: CME inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CME. The board's role is to monitor CME's management team and ensure that shareholders' interests are well served. CME's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CME's outside directors are responsible for providing unbiased perspectives on the board's policies.
Charles Carey, Vice Chairman of the Board
Hilda Piell, Chief Human Resource Officer, Senior Managing Director
Ana Dutra, Independent Director
Anita Liskey, Sr Communications
Daniel Glickman, Lead Independent Director
Deborah Lucas, Independent Director
Jack Tobin, Chief Accounting Officer
Larry Gerdes, Independent Director
Kathleen Cronin, Senior Managing Director, General Counsel, Corporate Secretary
Howard Siegel, Independent Director
Dennis Chookaszian, Independent Director
Kendal Vroman, Senior Managing Director - International and Optimization Services
Phyllis Lockett, Independent Director
Terry Savage, Independent Director
Jonathan Marcus, Sr Counsel
Derek Sammann, Senior Managing Director - Commodity and Options
Gedon Hertshten, Independent Director
Kevin Kometer, Chief Information Officer, Senior Managing Director
Julie Winkler, Senior Managing Director, Chief Commercial Officer
Elizabeth Cook, Independent Director
Ronald Pankau, Independent Director
Daniel Kaye, Independent Director
Yra Harris, Independent Director
Terrence Duffy, Executive Chairman of the Board, Chief Executive Officer
John Pietrowhicz, Chief Financial Officer
Michael Spencer, Director
John Peschier, Managing Relations
Martin Gepsman, Independent Director
Sunil Cutinho, President - CME Clearing
Julie Holzrichter, Chief Operating Officer, Senior Managing Director
William Hobert, Independent Director
Sean Tully, Senior Managing Director - Financial and OTC Products
Timothy Bitsberger, Independent Director
Patrick Maloney, Independent Director
Eileen Keeve, Managing Devel
William Shepard, Independent Director
Dennis Suskind, Independent Director

CME Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CME a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in CME Stock

When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.